Search…

Cancer early screening company Grail updates its 2025 cash burn guidance.

14/08/2025

Cancer early screening company Grail has updated its 2025 cash consumption guidance to $310 million, mainly due to the increase in adoption of its Galleri test product and expansion of partnerships. Thanks to the growth in test orders, the company reported a 93% year-on-year improvement in net loss.

Latest

1 m ago

Senior executive of Indian Bharat Petroleum Corporation: Due to discount issues, last month's import volume of Russian oil was affected.

2 m ago

Robotic concept stocks are pulling up against the trend, Wollongong Electric Drive hits the limit up and reaches a historical high.

2 m ago

The eruption of Chinese assets, foreign capital "real money" increasing investment in the Chinese market.

2 m ago

Laura Wang, Chief Stock Strategist of Morgan Stanley China, said in the latest report that foreign capital accelerated into the Chinese stock market in July, with long funds injecting $2.7 billion into the market, doubling from $1.2 billion in June. It is expected that the trend of foreign capital returning to the Chinese stock market will be "even stronger" in the future.

3 m ago

The European Union makes a second anti-dumping sunset review final ruling on China's aluminium foil: continuing to impose anti-dumping duties.

See all latest